Stakeholders seek more in-person meetings and faster guidance development from FDA
Regulatory NewsFerdous Al-Faruque
Diagnostics/IVDsGuidanceMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)